The post Google says Anthropic AI will remain available on Google Cloud despite Pentagon risk designation appeared on BitcoinEthereumNews.com. Google said it willThe post Google says Anthropic AI will remain available on Google Cloud despite Pentagon risk designation appeared on BitcoinEthereumNews.com. Google said it will

Google says Anthropic AI will remain available on Google Cloud despite Pentagon risk designation

For feedback or concerns regarding this content, please contact us at [email protected]

Google said it will continue offering artificial intelligence models from Anthropic to customers through its cloud platform, excluding defense-related work, a day after Microsoft issued a similar statement.

The announcements from two of the world’s largest cloud infrastructure providers follow the US Defense Department’s designation of Anthropic as a supply chain risk.

A Google spokesperson said Friday that the determination does not prevent the company from working with Anthropic on non defense related projects and that its products will remain available through platforms such as Google Cloud.

Anthropic’s Claude models are available through Google Cloud via the Vertex AI platform. Google is also a significant financial backer of the company. In January 2025, the search giant committed an additional $1 billion investment in Anthropic, adding to its previous $2 billion stake.

Anthropic uses Google Cloud infrastructure to train its models and recently expanded its partnership with the company, gaining access to up to one million of Google’s custom tensor processing units.

The dispute began after Anthropic declined to agree to new terms requested by the US Department of Defense regarding the use of its AI systems.

Following the disagreement, President Donald Trump instructed federal agencies to stop using Anthropic technology. Defense Secretary Pete Hegseth later said the Pentagon would phase out its work with the company over a six month period.

Some defense technology firms have already told employees to stop using Anthropic’s Claude models and switch to alternatives from rival providers such as OpenAI.

Microsoft was the first major cloud partner to confirm it would continue supporting Anthropic products despite the Pentagon designation.

Microsoft said Thursday that its lawyers reviewed the designation and concluded that Anthropic products, including Claude, can remain available to customers other than the Department of War.

Anthropic CEO Dario Amodei said the company plans to challenge the government’s supply chain risk designation in court.

A late Friday report confirmed that Amazon will also continue offering Anthropic’s artificial intelligence technology to its cloud customers, excluding work involving the Department of Defense.

Disclosure: This article was edited by Estefano Gomez. For more information on how we create and review content, see our Editorial Policy.

Source: https://cryptobriefing.com/anthropic-ai-availability-cloud/

Market Opportunity
Cloud Logo
Cloud Price(CLOUD)
$0.03723
$0.03723$0.03723
+0.54%
USD
Cloud (CLOUD) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09